control group:Simulation agent

4 trials

Sponsors

Chongqing Zhihui Institute of Traditional Chinese Medicine, Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Conditions

Acute ST-segment elevation myocardial infarctionmultidrug resistance tuberculosis

Early Phase 1

The clinical investigation of the curative effect about Nai-Lao-Kang combination with antituberculotics in MDR-TB

Active, not recruitingITMCTR2000003501

Chongqing Zhihui Institute of Traditional Chinese Medicinemultidrug resistance tuberculosis

Start: 2020-09-01Updated: 2023-02-20

The clinical investigation of the curative effect about Nai-Lao-Kang combination with antituberculotics in MDR-TB

Active, not recruitingChiCTR2000034800

Chongqing Zhihui Institute of Traditional Chinese Medicinemultidrug resistance tuberculosis

Start: 2020-09-01Updated: 2020-07-20

A study of musk in the treatment of microcirculation disorder after PPCI in acute ST-segment elevation myocardial infarction

Active, not recruitingChiCTR2000037470

Longhua Hospital affiliated to Shanghai University of Traditional Chinese MedicineAcute ST-segment elevation myocardial infarction

Start: 2020-10-01Updated: 2020-10-19

A study of musk in the treatment of microcirculation disorder after PPCI in acute ST-segment elevation myocardial infarction

Active, not recruitingITMCTR2000003817

Longhua Hospital affiliated to Shanghai University of Traditional Chinese MedicineAcute ST-segment elevation myocardial infarction

Start: 2020-10-01Updated: 2023-02-20